Optomed Oyj has seen no insider trading activity within the past ninety days. The most recent transactions occurred in August 2024, involving senior management selling and purchasing shares. Prior to that period, the Chief Executive Officer executed multiple acquisitions in March 2024. These historical movements represent the latest recorded equity adjustments by company leadership.